Veggiani Gianluca, Giabbai Barbara, Semrau Marta S, Medagli Barbara, Riccio Vincenzo, Bajc Gregor, Storici Paola, de Marco Ario
Lab of Environmental and Life Sciences, University of Nova Gorica, Vipavska cesta 13, 5000, Rožna Dolina, Nova Gorica, Slovenia.
Structural Biology Lab, Elettra Sincrotrone Trieste S.C.p.A., 34149, Basovizza, Trieste, Italy.
Protein Expr Purif. 2020 Feb;166:105505. doi: 10.1016/j.pep.2019.105505. Epub 2019 Sep 26.
Recombinant antibodies can be expressed as fusion constructs in combination with tags which simplify their engineering into reliable and homogeneous immunoreagents by allowing site-specific, 1:1 functionalization. Several tags and corresponding reagents for recombinant protein derivatization have been proposed but benchmarking surveys for the evaluation of their effect on the characteristics of recombinant antibodies have not been reported. In this work we evaluated the impact on expression yields, shelf-stability, thermostability and binding affinity of a set of C-terminal tags fused to the same anti-Her2 nanobody. Furthermore, we assessed the efficiency of the derivatization process. The constructs always bore a 6xHis tag plus either the controls (EGFP and C-tag) or CLIP, HALO, AviTag, the LEPTG sequence recognized by Sortase A (Sortase tag), or a free cysteine. The advantages and drawbacks of the different systems were analyzed and discussed.
重组抗体可以作为融合构建体与标签一起表达,这些标签通过实现位点特异性的1:1功能化,将其工程化为可靠且均匀的免疫试剂。已经提出了几种用于重组蛋白衍生化的标签和相应试剂,但尚未有关于评估它们对重组抗体特性影响的基准调查报道。在这项工作中,我们评估了一组与相同抗Her2纳米抗体融合的C端标签对表达产量、储存稳定性、热稳定性和结合亲和力的影响。此外,我们评估了衍生化过程的效率。构建体始终带有一个6xHis标签,再加上对照(EGFP和C标签)或CLIP、HALO、AviTag、被分选酶A识别的LEPTG序列(分选酶标签)或一个游离半胱氨酸。分析并讨论了不同系统的优缺点。